Avacta, Mologic partner for Covid-19 antigen test
The partnership is expected to offer a faster route to market Avacta’s rapid antigen test
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
08 Feb 21
The partnership is expected to offer a faster route to market Avacta’s rapid antigen test
08 Feb 21
Individuals can now collect only a few drops of blood at their homes and send their samples by…
05 Feb 21
The sensor technology will help the company to initially develop a rapid point-of-care Covid-19 test
04 Feb 21
The company’s tests leverage advanced machine learning algorithms to enhance patient decision-making
04 Feb 21
The new facility, located in Carlsbad, is expected to produce 600 million QuickVue SARS rapid antigen tests
02 Feb 21
The new test is designed to screen and detect multiple mutant variations in a single reaction
26 Jan 21
Biosensors aren't generally considered the most accurate when it comes to detecting a respiratory virus, but Korean researchers…
Royal Mail, DVLA, and Tate & Lyle Sugars are among the UK companies rolling out asymptomatic lateral flow…
25 Jan 21
The new diagnosis technique could mean patients with suspected prostate cancer can avoid a painful biopsy procedure in…
25 Jan 21
The novel swab is said to provide a sample concentration of up to 30 fold over other swabs…